Article Details

Lineage Announces Worldwide License Agreement With Immunomic Therapeutics for an ...

Retrieved on: 2021-04-20 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Lineage Announces Worldwide License Agreement With Immunomic Therapeutics for an .... View article details on HISWAI: https://www.oaoa.com/news/business/lineage-announces-worldwide-license-agreement-with-immunomic-therapeutics-for-an-allogeneic-cell-based-cancer-immunotherapy/article_bd394e9e-caa0-520c-9610-8bc68e9a81ea.html

Excerpt

(NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell transplants for serious medical conditions, today ...

Article found on: www.oaoa.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up